You do realise how they are selecting their candidates? Probably not given your recent commentary.
I now smirk when I see you commenting as you have indicated no longer having a holding. Perhaps stick to FB.
Stamler and team are working with neurologists seeking patients who have very early signs of MSA / Parkinsons. For this to occur there is a heavy reliance on a neurologist to a) detect and b) refer to ATH to be part of the trial.
By taking this route, there is a much higher chance of success for phase 2 - rather than simply opening up to anybody - which was part of the issue last time around.
I would rather have ATH get it right and then see positive results than open up to anybody and run the risk of further disappointment.
- Forums
- ASX - By Stock
- ATH
- Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial
Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial, page-10
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $2.733K | 832.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 45274833 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126718541 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 44856500 | 0.003 |
62 | 92776603 | 0.002 |
28 | 123111099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126718541 | 16 |
0.005 | 26858632 | 28 |
0.006 | 15243927 | 24 |
0.007 | 55868969 | 31 |
0.008 | 23800417 | 27 |
Last trade - 15.57pm 09/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |